Clover Health Investments, Corp.
CLOVNASDAQHealthcare● Active
$3.92
+$0.09(+2.35%)
Market Cap$2.0B
P/E Ratio—
52W High$4.23
52W Low$1.58
Clover Health Investments, Corp.（CLOV）· 现金流量表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · CLOV · 截至 2026-06-09
财务报表
Operating CF · CapEx · Free Cash Flow
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | ($0.09B) | ($0.04B) | ($0.21B) | ($0.34B) | ($0.59B) |
| Depreciation & Amort. | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Stock-Based Comp. | $0.10B | $0.11B | $0.14B | $0.16B | $0.16B |
| Change in Working Capital | ($0.08B) | $0.01B | ($0.06B) | ($0.00B) | $0.19B |
| Net Cash from Operations | ($0.07B) | $0.03B | ($0.12B) | ($0.20B) | ($0.28B) |
| Investing Activities | |||||
| Capital Expenditure | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Purchases of Investments | ($0.21B) | ($0.20B) | ($0.18B) | ($0.37B) | ($0.88B) |
| Sales of Investments | $0.21B | $0.20B | $0.32B | $0.49B | $0.44B |
| Net Cash from Investing | $0.00B | $0.00B | $0.14B | $0.10B | ($0.44B) |
| Financing Activities | |||||
| Common Stock Repurchased | ($0.06B) | ($0.02B) | ($0.01B) | ($0.01B) | ($0.00B) |
| Dividends Paid | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Debt Issued / Repaid | $0.00B | $0.00B | $0.00B | $0.00B | ($0.03B) |
| Net Cash from Financing | ($0.05B) | ($0.02B) | ($0.03B) | ($0.00B) | $0.93B |
| Free Cash Flow | |||||
| Free Cash Flow | ($0.07B) | $0.03B | ($0.12B) | ($0.21B) | ($0.28B) |
| FCF Margin %(computed) | -3.58% | 2.43% | -9.24% | -19.00% | -19.23% |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · B
深入了解Clover Health Investments, Corp.
关于Clover Health Investments, Corp.（CLOV）现金流量表
Clover Health Investments, Corp. 2025财年经营活动现金流($0.07B)，自由现金流($0.07B)（FCF利润率-3.58%），资本支出($0.00B)。
常见问题
CLOV · 4 问Clover Health Investments, Corp. 2025财年自由现金流($0.07B)，同比down307.2%。
CLOV free cash flowFCF margincash flow yield
· Source: FMP /stable/cash-flow-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09